Apr 14, 2026 02:08PM
Apr 14, 2026 02:08PM
Apr 14, 2026 08:54AM
Apr 14, 2026 08:54AM
Oct 22, 2025 07:05AM
Oct 22, 2025 07:00AM
Aug 14, 2024 07:04AM Galera Therapeutics (GRTX) Announces Board Approval of Complete Liquidation and Dissolution
Aug 14, 2024 07:00AM
May 13, 2024 07:00AM
May 3, 2024 07:03AM
May 3, 2024 07:00AM
Mar 28, 2024 07:00AM
Nov 14, 2023 07:00AM
Oct 31, 2023 07:01AM Galera Therapeutics (GRTX) says FDA reiterated need for additional Phase 3 trial of avasopasem manganese for radiotherapy-induced SOM
Oct 31, 2023 07:00AM
Sep 18, 2023 07:01AM
Sep 18, 2023 07:00AM
Sep 5, 2023 07:00AM
Aug 14, 2023 07:00AM
Aug 10, 2023 08:07AM
Aug 9, 2023 04:32PM Galera Therapeutics (GRTX) Receives CRL from U.S. FDA for Avasopasem Manganese
Aug 9, 2023 04:31PM
Jun 5, 2023 02:15PM
May 18, 2023 08:00AM
May 11, 2023 07:00AM
May 4, 2023 04:01PM
May 1, 2023 07:03AM
May 1, 2023 07:00AM Galera Expands Commercial Leadership Team
May 1, 2023 07:00AM
Apr 26, 2023 10:00AM
Apr 26, 2023 10:00AM
Mar 10, 2023 07:01AM
Mar 10, 2023 07:00AM
Mar 10, 2023 07:00AM
Mar 8, 2023 07:00AM Galera Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Updates
Mar 8, 2023 07:00AM
Feb 21, 2023 06:07PM
Feb 21, 2023 05:53AM
Feb 15, 2023 08:46AM
Feb 15, 2023 08:45AM
Feb 15, 2023 08:45AM
Feb 15, 2023 08:03AM Galera Therapeutics (GRTX) Announces FDA Acceptance and Priority Review of Avasopasem NDA for Radiotherapy-Induced Severe Oral Mucositis
Feb 15, 2023 08:00AM
Feb 15, 2023 08:00AM
Dec 12, 2022 07:01AM
Dec 12, 2022 07:00AM
Dec 12, 2022 07:00AM
Nov 9, 2022 07:00AM
Nov 9, 2022 07:00AM Galera Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
Oct 26, 2022 01:40PM

323,573 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All